ANTIPHOSPHOLIPID ANTIBODIES IN HEALTHY PREGNANT WOMEN

Alarco´n-Segovia, 1989, Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: A prospective analysis of 500 consecutive patients, Medicine, 68, 353, 10.1097/00005792-198911000-00003 Alarco´n-Segovia, 1992, Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus, Semin Arthritis Rheum, 21, 275, 10.1016/0049-0172(92)90021-5 Aron, 1995, Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome, Int Arch Allergy Immunol, 106, 8, 10.1159/000236883 Asherson, 1989, The “primary” antiphospholipid syndrome: Major clinical and serological features, Medicine, 68, 366, 10.1097/00005792-198911000-00004 Bendon, 1990, Prenatal screening for anticardiolipin antibody, Am J Perinatol, 7, 245, 10.1055/s-2007-999492 Boklage, 1990, Survival probability of human conception from fertilization to term, Int J Fertil, 35, 75 Bonnar, 1977, Acute and chronic coagulation problems in pregnancy, 363 Branch, 1985, Obstetric complications associated with the lupus anticoagulant, N Engl J Med, 313, 1322, 10.1056/NEJM198511213132104 Branch, 1989, The association of antiphospholipid antibodies with severe preeclampsia, Obstet Gynecol, 73, 541 Branch, 1990, Clinical implications of antiphospholipid antibodies: The Utah experience, 335 Branch, 1990, Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: A model for autoimmune fetal loss, Am J Obstet Gynecol, 163, 210, 10.1016/S0002-9378(11)90700-5 Branch, 1990, Antiphospholipid antibodies and pregnancy: Maternal implications, Semin Perinatol, 14, 139 Branch, 1992, Antiphospholipid antibodies and fetal loss, N Engl J Med, 326, 952 Branch, 1992, Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience, Obstet Gynecol, 80, 614 Branch P, Silver RM, Pierangeli SS, et al. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls and antiphospholipid syndrome. Obstet Gynecol, in press. Branch, 1996, Criteria for antiphospholipid syndrome: Early pregnancy loss or recurrent pregnancy loss?, Lupus, 5, 409, 10.1177/096120339600500515 Cowchock, 1991, Autoantibodies and pregnancy wastage, Am J Reprod Immunol, 26, 38, 10.1111/j.1600-0897.1991.tb00700.x Dekker, 1993, Low dose aspirin in the prevention of preeclampsia and fetal growth retardation: Rationale, mechanisms, and clinical trials, Am J Obstet Gynecol, 168, 214, 10.1016/S0002-9378(12)90917-5 Derksen, 1986, Discordant effects of prednisone on anticardiolipin antibodies and the lupus anticoagulant, Arthritis Rheum, 29, 1295, 10.1002/art.1780291021 Derksen, 1992, Detection of the lupus anticoagulant in pregnancy, Clin Exp Rheumatol, 10, 323 El-Roeiy, 1988, Definition of normal autoantibody levels in an apparently healthy population, Obstet Gynecol, 72, 597 El-Roeiy, 1990, The prevalence of autoantibodies and lupus anticoagulant in healthy pregnant women, Obstet Gynecol, 75, 391 Fishman, 1993, Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3, J Clin Invest, 91, 1834, 10.1172/JCI116396 Galli, 1990, Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor, Lancet, 335, 1544, 10.1016/0140-6736(90)91374-J Ginsberg, 1992, Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: A cross-sectional study, Blood, 80, 975, 10.1182/blood.V80.4.975.975 Greenspoon, 1989, Fetal distress associated with the anticardiolipin antibody and a history of intrauterine fetal demise: A case report, J Reprod Med, 34, 311 Haddow, 1991, Lack of an association between late fetal death and antiphospholipid antibody measurements in the second trimester, Am J Obstet Gynecol, 165, 1308, 10.1016/S0002-9378(12)90749-8 Harger, 1983, Etiology of recurrent pregnancy loss and outcomes of subsequent pregnancies, Obstet Gynecol, 62, 574 Harris, 1983, Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus, Lancet, 2, 1211, 10.1016/S0140-6736(83)91267-9 Harris, 1986, Thrombosis, recurrent fetal loss, and thrombocytopenia, Arch Intern Med, 146, 2153, 10.1001/archinte.146.11.2153 Harris, 1986, Syndrome of the black swan, Br J Rheumatol, 26, 324, 10.1093/rheumatology/26.5.324 Harris, 1988, Solid-phase anti-cardiolipin test revisited, Am J Med, 85, 599, 10.1016/S0002-9343(88)80228-6 Harris, 1990, The second international anti-cardiolipin standardization workshop/the Kingston antiphospholipid antibody study (KAPS) group, Am J Clin Pathol, 94, 476, 10.1093/ajcp/94.4.476 Harris, 1991, Should anticardiolipin tests be performed in otherwise healthy pregnant women?, Am J Obstet Gynecol, 165, 1272, 10.1016/S0002-9378(12)90741-3 Harris, 1994, Antiphospholipid antibodies—middle aged but robust, J Rheumatol, 21, 978 Hughes, 1989, The anticardiolipin syndrome, J Rheumatol, 13, 486 Hughes, 1993, The antiphospholipid antibody syndrome: Ten years on, Lancet, 342, 341, 10.1016/0140-6736(93)91477-4 Infante-Rivard, 1991, Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case–control study, N Engl J Med, 325, 1063, 10.1056/NEJM199110103251503 Isenberg, 1986, The relationship of anti-DNA antibody idiotypes and anticardiolipin antibodies to disease activity in systemic lupus erythematosus, Medicine, 65, 46, 10.1097/00005792-198601000-00003 Ishii, 1990, Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus, Ann Rheum Dis, 49, 387, 10.1136/ard.49.6.387 Kalunian, 1988, Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus, Am J Med, 85, 602, 10.1016/S0002-9343(88)80229-8 Keane, 1989, A serial study of anticardiolipin antibody and antimitochondrial antibody type M5 in a patient with polyarthritis and polymyositis, Br J Rheumatol, 28, 158, 10.1093/rheumatology/28.2.158 Kilpatrick, 1989, Anti-phospholipid antibody syndrome and pre-eclampsia, Lancet, ii, 987, 10.1016/S0140-6736(89)91001-5 Kline, 1987, Epidemiology of chromosomal anomalies in spontaneous abortion: Prevalence, manifestation and determinants, 29 Kochenour, 1987, A new postpartum syndrome associated with antiphospholipid antibodies, Obstet Gynecol, 69, 460 Koskela, 1988, Significance of false-positive syphilis reactions and anticardiolipin antibodies in a nationwide series of pregnant women, J Rheumatol, 15, 70 Kutteh, 1993, Association of anticardiolipin antibodies and pregnancy loss in women with systemic lupus erythematosus, Fertil Steril, 60, 449, 10.1016/S0015-0282(16)56159-7 Laird, 1982, Random-effects models for longitudinal data, Biometrics, 38, 963, 10.2307/2529876 Laskin, 1988, Anticardiolipin antibodies: Smoking gun or smoke screen?, J Rheumatol, 15, 7 Lima, 1996, A study of sixty pregnancies in patients with the antiphospholipid syndrome, Clin Exp Rheumatol, 14, 131 Lockshin, 1985, Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus, N Engl J Med, 313, 152, 10.1056/NEJM198507183130304 Lockshin, 1987, Antibody to cardiolipin, lupus anticoagulant, and fetal death, J Rheumatol, 14, 259 Lockshin, 1989, Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody, Am J Obstet Gynecol, 160, 439, 10.1016/0002-9378(89)90468-7 Lockshin, 1994, Antiphospholipid antibody syndrome, Rheum Dis Clin North Am, 20, 45, 10.1016/S0889-857X(21)00225-8 Lockwood, 1989, The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population, Am J Obstet Gynecol, 161, 369, 10.1016/0002-9378(89)90522-X Lockwood, 1994, The immunobiology and obstetrical consequences of antiphospholipid antibodies, Obstet Gynecol Surv, 49, 432, 10.1097/00006254-199406000-00026 Loizou, 1988, Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus, Quart J Med, 68, 526 Love, 1990, Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE), Ann Intern Med, 112, 682, 10.7326/0003-4819-112-9-682 Lubbe, 1983, Fetal survival after prednisone suppression of maternal lupus-anticoagulant, Lancet, 1, 1361, 10.1016/S0140-6736(83)92141-4 Lubbe, 1983, Chorea gravidarum association with circulating lupus anticoagulant: successful outcome of pregnancy with prednisone and aspirin therapy: Case report, Br J Obstet Gynaecol, 90, 487, 10.1111/j.1471-0528.1983.tb08950.x Lynch, 1994, Antiphospholipid antibodies in predicting adverse pregnancy outcome, Ann Intern Med, 120, 470, 10.7326/0003-4819-120-6-199403150-00004 Lynch, 1995, Longitudinal measurement of anticardiolipin antibodies during normal pregnancy: A prospective study, Lupus, 4, 365, 10.1177/096120339500400506 Matsurra, 1990, Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease, Lancet, 336, 177, 10.1016/0140-6736(90)91697-9 Matsurra, 1992, Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor, J Immunol, 148, 3885 May, 1993, Different manifestations of the antiphospholipid antibody syndrome in a family with systemic lupus erythematosus, Arthritis Rheum, 36, 528, 10.1002/art.1780360413 McNeil, 1990, Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation, b2-glycoprotein I (apolipoprotein H), Proc Natl Acad Sci USA, 87, 4120, 10.1073/pnas.87.11.4120 Ornstein, 1994, An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy: A report of 2 cases, J Rheumatol, 21, 1360 Oshiro, 1996, Antiphospholipid antibodies and fetal death, Obstet Gynecol, 87, 489, 10.1016/0029-7844(95)00498-X Out, 1989, Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: A prospective study, Ann Rheum Dis, 48, 1023, 10.1136/ard.48.12.1023 Out, 1991, Prevalence of antiphospholipid antibodies in patients with fetal loss, Ann Rheum Dis, 50, 553, 10.1136/ard.50.8.553 Out, 1992, Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus, J Rheum Dis, 51, 353, 10.1136/ard.51.3.353 Pattison, 1993, Antiphospholipid antibodies in pregnancy: Prevalence and clinical associations, Br J Obstet Gynaecol, 100, 909, 10.1111/j.1471-0528.1993.tb15105.x Peaceman, 1992, Interlaboratory variation in antiphospholipid antibody testing, Am J Obstet Gynecol, 166, 1780, 10.1016/0002-9378(92)91569-V Perez, 1991, Anticardiolipin antibodies in unselected pregnant women. Relationship to fetal outcome, J Perinatol, 11, 33 Petri, 1992, The Hopkins Lupus Pregnancy Center: 1987–1991 update, Am J Reprod Immunol, 28, 188, 10.1111/j.1600-0897.1992.tb00788.x Petri, 1994, Systemic lupus erythematosus and pregnancy, Rheum Dis Clin North Am, 20, 87, 10.1016/S0889-857X(21)00227-1 Polzin, 1991, The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction, Obstet Gynecol, 78, 1108 Qamar, 1990, Characteristics of high-titer IgG antiphospholipid antibody in systemic lupus erythematosus patients with and without fetal death, Arthritis Rheum, 33, 501, 10.1002/art.1780330406 Rafla, 1991, Lupus anticoagulant in pre-eclampsia and intra-uterine growth retardation, Eur J Obstet Gynecol Reprod Biol, 42, 167, 10.1016/0028-2243(91)90214-6 Ramsey-Goldman, 1992, Previous pregnancy outcome is an important determinant of subsequent pregnancy outcome in women with systemic lupus erythematosus, Am J Reprod Immunol, 28, 195, 10.1111/j.1600-0897.1992.tb00790.x Ramsey-Goldman, 1993, Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus, Am J Epidemiol, 138, 1057, 10.1093/oxfordjournals.aje.a116824 Reyes, 1994, Antiphospholipid antibodies: A critique of their heterogeneity and hegemony, Semin Thromb Hemost, 20, 89, 10.1055/s-2007-1001893 Rix, 1992, Lupus anticoagulation and anticardiolipin antibodies in an obstetric population, Acta Obstet Gynecol Scand, 71, 605, 10.3109/00016349209006228 Robinson, 1992, Evidence of antiphospholipid antibodies in an obstetric population (abstract P2-40) Rote, 1990, Antiphospholipid antibodies and recurrent pregnancy loss: Correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin, Am J Obstet Gynecol, 163, 575, 10.1016/0002-9378(90)91201-M Rote, 1992, Antiphospholipid antibodies—lobsters or red herrings?, Am J Reprod Immunol Microbiol, 28, 31, 10.1111/j.1600-0897.1992.tb00753.x Roubey, 1994, Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other “antiphospholipid” autoantibodies, Blood, 84, 2854, 10.1182/blood.V84.9.2854.2854 Schei, 1995, Can maternal antiphospholipid antibodies predict the birth of a small-for-gestational age child?, Acta Obstet Gynecol Scand, 74, 425, 10.3109/00016349509024403 Scott, 1987, Anti-cardiolipin antibodies and preeclampsia, Br J Obstet Gynaecol, 94, 604, 10.1111/j.1471-0528.1987.tb03162.x Sheridan-Pereira, 1988, Neonatal aortic thrombosis associated with the lupus anticoagulant, Obstet Gynecol, 71, 1016 Silver, 1994, Clinical consequences of antiphospholipid antibodies: An historic cohort study, Obstet Gynecol, 83, 372 Silver, 1994, Recurrent miscarriage: Autoimmune considerations, Clin Obstet Gynecol, 37, 745, 10.1097/00003081-199409000-00025 Silver, 1996, Anticardiolipin antibodies: Clinical consequences of “low titers.”, Obstet Gynecol, 87, 494, 10.1016/0029-7844(95)00497-1 Sletnes, 1992, Antiphospholipid antibodies in pre-eclamptic women: Relation to growth retardation and neonatal outcome, Acta Obstet Gynecol Scand, 71, 112, 10.3109/00016349209007966 Soloninka, 1991, Clinical utility and specificity of anticardiolipin antibodies, J Rheumatol, 18, 1849 Stafford-Brady, 1988, Successful pregnancy in systemic lupus erythematosus with an untreated lupus anticoagulant, Arch Intern Med, 148, 1647, 10.1001/archinte.148.7.1647 Stirrat, 1990, Recurrent miscarriage II: Clinical associations, causes, and management, Lancet, 336, 728, 10.1016/0140-6736(90)92215-4 Stuart, 1993, A prospective study of pregnancy outcome in women screened at a routine antenatal clinic for anticardiolipin antibodies, Br J Obstet Gynaecol, 100, 599, 10.1111/j.1471-0528.1993.tb15319.x Sturfelt, 1987, Anticardiolipin antibodies in patients with systemic lupus erythematosus, Arthritis Rheum, 30, 382, 10.1002/art.1780300404 Tan, 1982, The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 25, 1271, 10.1002/art.1780251101 Taylor, 1991, Pre-eclampsia and anti-phospholipid antibody, Br J Obstet Gynaecol, 98, 604, 10.1111/j.1471-0528.1991.tb10382.x Triplett, 1989, Antiphospholipid antibodies and reproduction, Am J Reprod Immunol, 21, 123, 10.1111/j.1600-0897.1989.tb01016.x Triplett, 1989, Antiphospholipid antibodies and recurrent pregnancy loss, Am J Reprod Immunol, 20, 52, 10.1111/j.1600-0897.1989.tb00639.x Triplett, 1992, Antiphospholipid antibodies: Proposed mechanisms of action, Am J Reprod Immunol, 28, 211, 10.1111/j.1600-0897.1992.tb00794.x Triplett, 1994, New diagnostic strategies for lupus anticoagulants and antiphospholipid antibodies, Haemostasis, 24, 155 Wilcox, 1988, Incidence of early loss in pregnancy, N Engl J Med, 319, 189, 10.1056/NEJM198807283190401